Category Archives: Blog

POLARISqb talks with QuBites from Valorem Reply

QuBites S6 E6

We were excited to engage in this fantastic conversation with Rene Schulte about our company and the work that we are doing. He talks with our CEO, Dr. Shahar Keinan, about  utilizing the power of quantum optimization to power the quantum drug discovery we have made in the last three years. The episode talks about the progress in quantum annealers for multi-variable optimization, progress in the sector that is using AI and Machine Learning, and how that progress is integrated into the Tachyon system that POLARISqb has built to accelerate drug design. Dr. Keinan talks about how we are translating chemistry constraints into QUBOs that are able to be used via quantum computing to optimize multiple interconnected variables in ways that conventional high powered computers would still take months or even years to solve.

Hackathons Power Collaboration and Innovation
An essential part of our philosophy for success in drug discovery is our quarterly hackathon, a hands-on technical challenge that our entire team works together to solve. As a data and science-led organization, these hackathons keep our team working collaboratively across departments and integrating innovations from across the fields of bioscience, pharmaceuticals, computing, and quantum…
Read more
QC Designs a Different Molecule
Drug discovery is a complicated process of identifying a small molecule that can bind to a specific protein pocket and change disease progression by blocking (or enhancing) the activity of that protein. Not only does it have to interact with the protein in a favorable manner, but it also must have the properties that make…
QC Designs a Different MoleculeQC Designs a Different Molecule
Read more
POLARISqb and Auransa Announce Promising Results for Triple Negative Breast Cancer using Quantum Computing and AI
Auransa, Inc.,an AI biotech and Polaris Quantum Biotech (Polarisqb), a quantum based drug design company, announce progress on important breast cancer target. PALO ALTO, CA, DURHAM, NC, USA, August 9, 2022 /EINPresswire.com/ -- Auransa, Inc., an artificial intelligence (AI) company developing precision medicines in areas of unmet medical needs, and Polaris Quantum Biotech (Polarisqb), a…
POLARISqb and Auransa Announce Promising Results for Triple Negative Breast Cancer using Quantum Computing and AIPOLARISqb and Auransa Announce Promising Results for Triple Negative Breast Cancer using Quantum Computing and AI
Read more